$25.16-0.13|(-0.51%)
52W H: 31.7752W L: 18.79Beta: 1.66

About Arcutis Biotherapeutics Inc

Frequently Asked Questions

What is the 52-week range for ARQT?

The 52-week high is $31.77 and the 52-week low is $18.79.

What is the P/E ratio for ARQT?

The Price to Earnings (P/E) ratio is 111.20.

What is the dividend yield for ARQT?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is 15.05%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 6.15%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 18.77.

Analyst Recommendation Trends

Wall Street analyst consensus for ARQT over the last few months:

2026-09-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0
2026-08-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0
2026-07-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0
2026-06-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0

Latest ARQT News

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the grant of an aggregate of 62,500 restricted stock units (RSUs) of Arcutis common stock to six newly hired employees. These awards were approved by the Compensation Committee of Arcutis’ Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022

Yahoo10/2/2026

Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study

MRK's tulisokibart meets the phase IIb HS study's primary endpoint, with high and medium-dose regimens showing superiority over placebo at week 16.

Yahoo10/1/2026

Arcutis Biotherapeutics (NASDAQ:ARQT) Delivers High Growth and Improving Fundamentals

Louis Navellier’s Little Book growth screen highlights Arcutis Biotherapeutics (ARQT) as ZORYVE fuels strong earnings, sales, and cash flow momentum.

ChartMill10/1/2026

Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options

Simone Biles opens up about her experience managing the symptoms of these conditions and encourages long-term control of skin healthBiles’ treatment, ZORYVE® (roflumilast), is the #1 prescribed branded topical therapy for three major inflammatory skin conditions combined — seborrheic dermatitis, eczema, and plaque psoriasis WESTLAKE VILLAGE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing

Yahoo9/29/2026

AXT Inc. (AXTI) Climbs 16% on S&P 600 Addition

AXT Inc. (NASDAQ:AXTI) extended its winning streak to a fifth straight day on Monday, surging by as much as 16.4 percent in intraday trading to $81.50, as investors resumed buying positions amid its official membership in the S&P 600 index. Effective on the same day, the listed firm officially joined the S&P 600 index alongside […]

Yahoo9/21/2026

Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?

Orchestra BioMed Holdings, Inc. (OBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Yahoo9/21/2026

Arcutis Biotherapeutics (NASDAQ:ARQT): Affordable Growth With Strong Upside Potential

Arcutis Biotherapeutics (ARQT) offers strong growth, reasonable industry valuation, and decent financial health—key affordable growth traits.

ChartMill9/21/2026

Arcutis Biotherapeutics (NASDAQ:ARQT): Strong Growth Meets a High-Quality Technical Setup

Arcutis Biotherapeutics (ARQT) shows strong growth and a promising technical setup as ZORYVE drives profitability and revenue gains.

ChartMill9/19/2026

RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study

Roche's Lunsumio-Revlimid combo meets its study goal in second-line or later follicular lymphoma, improving PFS versus rituximab plus Revlimid.

Yahoo9/17/2026

Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last?

Arcutis Biotherapeutics (ARQT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Yahoo9/17/2026

Here’s What Arcutis’ CEO Said at the Morgan Stanley Healthcare Conference That Made the Stock Jump 11%

Key TakeawaysConference Pop: Arcutis Biotherapeutics stock jumped 11. 19% on September 16, closing at $26.

Yahoo9/17/2026

Arcutis Biotherapeutics, Inc. (ARQT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Arcutis Biotherapeutics, Inc. (ARQT) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 1:50 PM EDTCompany ParticipantsTodd Watanabe...

SeekingAlpha9/16/2026

Arcutis Biotherapeutics (NASDAQ:ARQT) Delivers High Growth with Improving Fundamentals

Arcutis (ARQT) passes Navellier's 8 growth rules: EPS, revenue, and cash flow surging. A top pick for growth investors.

ChartMill9/7/2026

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 21, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.

Yahoo9/4/2026

Related Stocks (Peers)

Companies operating in similar sectors to ARQT:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-16Matsuda Masaru-3,674$25.0009$91,853
2026-09-15Welgus Howard G.-2,255--
2026-09-15Welgus Howard G.-1,019--
2026-09-15Welgus Howard G.-822--
2026-09-15Welgus Howard G.-4,730$24.18$114,371
2026-09-15Welgus Howard G.+2,255$8.63$19,461
2026-09-15Welgus Howard G.+1,019$7.51$7,653
2026-09-15Welgus Howard G.+822$6.5223$5,361
2026-09-08Matsuda Masaru-9,989$25.0261$249,986
2026-08-27Curran Terrie-27,052--
2026-08-27Curran Terrie-11,148--
2026-08-27Curran Terrie-27,052$25.0294$677,095
2026-08-27Curran Terrie+27,052$8.63$233,459
2026-08-27Curran Terrie-11,148$25.0294$279,028
2026-08-27Curran Terrie+11,148$7.51$83,721
2026-08-20Curran Terrie-1,072--
2026-08-20Curran Terrie-1,072$26.0376$27,912
2026-08-20Curran Terrie+1,072$7.51$8,051
2026-08-19Burnett Patrick-1,697$27$45,819
2026-08-17Welgus Howard G.-2,255--
2026-08-17Welgus Howard G.-1,019--
2026-08-17Welgus Howard G.-822--
2026-08-17Welgus Howard G.-4,730$26.1807$123,835
2026-08-17Welgus Howard G.+2,255$8.63$19,461
2026-08-17Welgus Howard G.+1,019$7.51$7,653
2026-08-17Welgus Howard G.+822$6.5223$5,361
2026-08-12Burnett Patrick-6,700--
2026-08-12Burnett Patrick-6,700$26.0847$174,767
2026-08-12Burnett Patrick+6,700$3.64$24,388
2026-08-11Burnett Patrick-8,300--
2026-08-11Burnett Patrick-8,300$26.5216$220,129
2026-08-11Burnett Patrick+8,300$3.64$30,212
2026-08-03Matsuda Masaru-1,230$26.1168$32,124
2026-08-03Watanabe Todd-4,375$26.1168$114,261
2026-08-03Burnett Patrick-955$26.1168$24,942
2026-07-15Welgus Howard G.-2,255--
2026-07-15Welgus Howard G.-1,019--
2026-07-15Welgus Howard G.-822--
2026-07-15Welgus Howard G.-4,730$26.91$127,284
2026-07-15Welgus Howard G.+2,255$8.63$19,461
2026-07-15Welgus Howard G.+1,019$7.51$7,653
2026-07-15Welgus Howard G.+822$6.5223$5,361
2026-07-15Peetz Christopher+13,010--
2026-07-15Peetz Christopher+21,486--
2026-07-15Peetz Christopher+4,315--
2026-06-05LIN SUE-JEAN+16,667--
2026-06-05LIN SUE-JEAN+5,778--
2026-06-05Welgus Howard G.+16,667--
2026-06-05Welgus Howard G.+5,778--
2026-06-05Krishnamohan Neha+16,667--
2026-06-05Krishnamohan Neha+5,778--
2026-06-05Curran Terrie+16,667--
2026-06-05Curran Terrie+5,778--
2026-06-05Munshi Amit+16,667--
2026-06-05Munshi Amit+5,778--
2026-06-05Gilbert Halley E+16,667--
2026-06-05Gilbert Halley E+5,778--
2026-06-05Leonard Keith R+16,667--
2026-06-05Leonard Keith R+5,778--
2026-06-05Heron Patrick J+16,667--
2026-06-05Heron Patrick J+5,778--
2026-05-11Vairavan Latha-435$21.05$9,157
2026-05-11Burnett Patrick-222$21.05$4,673
2026-05-04Vairavan Latha-1,341$23.6106$31,662
2026-05-04Watanabe Todd-3,172$23.6106$74,893
2026-05-04Matsuda Masaru-884$23.6106$20,872
2026-05-04Matsuda Masaru-7,372$23.2696$171,543
2026-05-04Burnett Patrick-684$23.6106$16,150
2026-05-01Welgus Howard G.-7,144$22.9871$164,220
2026-04-01Welgus Howard G.-10,000$23.8801$238,801
2026-03-02Welgus Howard G.-10,000$25.6518$256,518
2026-03-02Leonard Keith R-12,220--
2026-03-02Leonard Keith R-27,052--
2026-03-02Leonard Keith R-39,272$25.392$997,195
2026-03-02Leonard Keith R+12,220$7.51$91,772
2026-03-02Leonard Keith R+27,052$8.63$233,459
2026-03-02Edwards Larry Todd-103$25.9149$2,669
2026-03-02Edwards Larry Todd-3,584$25.161$90,177
2026-03-02Watanabe Todd-1,068$25.9139$27,676
2026-03-02Watanabe Todd-36,281$25.1606$912,852
2026-03-02Matsuda Masaru-1,987$25.7$51,066
2026-03-02Matsuda Masaru-193$25.9139$5,001
2026-03-02Matsuda Masaru-6,553$25.1604$164,876
2026-03-02Vairavan Latha-81$25.914$2,099
2026-03-02Vairavan Latha-2,772$25.1605$69,745
2026-03-02Burnett Patrick-181$25.914$4,690
2026-03-02Burnett Patrick-6,106$25.1604$153,629
2026-02-27Edwards Larry Todd+77,000--
2026-02-27Edwards Larry Todd+30,000--
2026-02-27Watanabe Todd+266,000--
2026-02-27Watanabe Todd+102,000--
2026-02-27Matsuda Masaru+97,000--
2026-02-27Matsuda Masaru-3,325$27.95$92,934
2026-02-27Matsuda Masaru+37,000--
2026-02-27Vairavan Latha+70,000--
2026-02-27Vairavan Latha+27,000--
2026-02-27Burnett Patrick+77,000--
2026-02-27Burnett Patrick+30,000--
2026-02-04Burnett Patrick-9,794$25.8064$252,748
2026-02-02Matsuda Masaru-4,714$25.63$120,820
2026-02-02Matsuda Masaru-19,379$25.24$489,126
2026-02-02Matsuda Masaru-8,562$24.97$213,793
2026-02-02Matsuda Masaru-7,983$25.4984$203,554
2026-02-02Watanabe Todd-19,833$25.4984$505,710
2026-02-02Vairavan Latha-1,320$25.4984$33,658
2026-02-02Welgus Howard G.-10,000$25.0483$250,483
2026-02-02Edwards Larry Todd-2,052$25.4984$52,323
2026-02-02Burnett Patrick-3,675$25.4984$93,707
2026-01-05Burnett Patrick-2,490$28.9822$72,166
2026-01-02Welgus Howard G.-10,000$28.9606$289,606
2025-12-31Burnett Patrick-1,156$29.3893$33,974
2025-12-31Burnett Patrick-541$28.81$15,586
2025-12-15Burnett Patrick-11,500--
2025-12-15Burnett Patrick-11,500$28.9436$332,851
2025-12-15Burnett Patrick+11,500$3.64$41,860
2025-12-04Munshi Amit+6,177--
2025-12-04Munshi Amit+16,502--
2025-12-04Munshi Amit+2,021--
2025-12-01Welgus Howard G.-10,000$30.2133$302,133
2025-12-01Matsuda Masaru-1,657$30.23$50,091
2025-11-24LIN SUE-JEAN-7,220--
2025-11-24LIN SUE-JEAN-18,052--
2025-11-24LIN SUE-JEAN-25,272$30.7833$777,956
2025-11-24LIN SUE-JEAN+7,220$7.51$54,222
2025-11-24LIN SUE-JEAN+18,052$8.63$155,789
2025-11-24Watanabe Todd-48,945$30.3556$1,485,755
2025-11-21Watanabe Todd-1,055$30$31,650
2025-11-20Gilbert Halley E-12,220--
2025-11-20Gilbert Halley E-16,532$27.5491$455,442
2025-11-20Gilbert Halley E+12,220$7.51$91,772
2025-11-19Matsuda Masaru-1,561$28.5$44,489
2025-11-19Matsuda Masaru-989$27.9541$27,647
2025-11-13Krishnamohan Neha-12,220--
2025-11-13Krishnamohan Neha-27,052--
2025-11-13Krishnamohan Neha-1,232$23.37$28,792
2025-11-13Krishnamohan Neha-39,272$23.1896$910,702
2025-11-13Krishnamohan Neha+12,220$7.51$91,772
2025-11-13Krishnamohan Neha+27,052$8.63$233,459
2025-11-13Leonard Keith R-4,312--
2025-11-06Edwards Larry Todd-29,131$25.1597$732,927
2025-11-06Burnett Patrick-17,250--
2025-11-06Burnett Patrick-17,250$24.1823$417,145
2025-11-06Burnett Patrick+17,250$3.64$62,790
2025-11-05Burnett Patrick-3,864$23.7172$91,643
2025-11-03Vairavan Latha-88$24.7185$2,175
2025-11-03Watanabe Todd-69$25.3991$1,753
2025-11-03Watanabe Todd-11,478$24.7122$283,647
2025-11-03Welgus Howard G.-10,000$25.2669$252,669
2025-11-03Matsuda Masaru-43$25.3985$1,092
2025-11-03Matsuda Masaru-7,165$24.7123$177,064
2025-11-03Burnett Patrick-15$25.4$381
2025-11-03Burnett Patrick-2,607$24.7124$64,425
2025-10-28Watanabe Todd-40,000$25.0258$1,001,032